tiprankstipranks
Hansa Biopharma AB (SE:HNSA)
:HNSA
Sweden Market
HNSA
Hansa Biopharma AB
RESEARCH TOOLSreports

Hansa Biopharma AB (HNSA) Income Statement

15 Followers

Hansa Biopharma AB Income Statement

Last quarter (Q4 2025), Hansa Biopharma AB's total revenue was kr75.99M, an increase of 134.99% from the same quarter last year. In Q4, Hansa Biopharma AB's net income was kr-165.04M. See Hansa Biopharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 222.26Mkr 171.32Mkr 134.09Mkr 154.53Mkr 33.88M
Gross Profit
kr 138.71Mkr 87.76Mkr 70.95Mkr 116.05Mkr 18.45M
Operating Expenses
kr 659.42Mkr 725.64Mkr 859.45Mkr 692.17Mkr 558.03M
Depreciation and Amortization
kr 0.00kr 28.06Mkr 10.74Mkr 12.05Mkr 8.61M
EBITDA
kr -409.35Mkr -642.07Mkr -714.55Mkr -554.26Mkr -538.83M
Operating Income
kr -520.71Mkr -637.88Mkr -788.50Mkr -576.12Mkr -539.58M
Other Income/Expenses
kr -6.27Mkr -166.33Mkr -42.32Mkr -33.86Mkr -1.15M
Pretax Income
kr -526.98Mkr -804.21Mkr -830.81Mkr -609.98Mkr -548.13M
Net Income
kr -529.25Mkr -807.24Mkr -831.72Mkr -611.13Mkr -548.28M
Per Share Metrics
Basic EPS
kr -6.52kr -12.84kr -15.83kr -13.60kr -12.33
Diluted EPS
kr -6.52kr -12.84kr -15.83kr -13.60kr -12.33
Weighted Average Shares Outstanding
 81.20M 62.83M 52.54M 44.92M 44.47M
Weighted Average Shares Outstanding (Diluted)
 81.20M 62.83M 52.54M 44.92M 44.47M
Currency in SEK

Hansa Biopharma AB Earnings and Revenue History